Skip Navigation


Brain Advance Access originally published online on October 18, 2006
Brain 2007 130(2):394-403; doi:10.1093/brain/awl284
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
130/2/394    most recent
awl284v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fabrizi, G. M.
Right arrow Articles by Rizzuto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabrizi, G. M.
Right arrow Articles by Rizzuto, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Charcot–Marie–Tooth disease type 2E, a disorder of the cytoskeleton

Gian Maria Fabrizi1, Tiziana Cavallaro1, Chiara Angiari1, Ilaria Cabrini1, Federica Taioli1, Giovanni Malerba2, Laura Bertolasi1 and Nicolo' Rizzuto1

1 Section of Clinical Neurology, Department of Neurological and Visual Sciences, University of Verona Italy 2 Section of Biology and Genetics, Department of Mother and Child and Biology-Genetics, University of Verona Italy

Correspondence to: Dr Gian Maria Fabrizi, Section of Clinical Neurology, Department of Neurological and Visual Sciences, University of Verona. Policlinico "G.B. Rossi", P.le L.A. Scuro 10, 37134 Verona, Italy E-mail: gianmaria.fabrizi{at}univr.it

The neurofilament light chain (NF-L) is a major constituent of intermediate filaments and plays a pivotal function in the assembly and maintenance of axonal cytoskeleton. Mutations in the NF-L gene (NEFL) cause autosomal dominant neuropathies that are classified either as axonal Charcot–Marie–Tooth (CMT) type 2E (CMT2E) or demyelinating CMT type 1F (CMT1F). The pathophysiological bases of the disorder(s) are elusive. We performed a mutational analysis of NEFL in a series of 177 index cases with CMT and without mutations in the genes for peripheral myelin protein zero (MPZ), peripheral myelin protein 22 (PMP22) and connexin 32 (GJB1); the motor nerve conduction velocity (MNCV) at the median nerve was below 38 m/s in 76 cases and above 38 m/s in 101. We identified five new pedigrees with four mutations in the head and rod domains of NF-L, including a novel Leu268Pro substitution and a novel del322Cys_326Asn deletion. Several examined affected members exhibited marked variability in the severity of disease and age at onset. Nerve conduction alterations were consistent with an axonal neuropathy often associated with demyelinating features, such as prolonged distal latencies (DL). Pathological examination of sural nerve biopsies in the probands detected in four cases a chronic axonal neuropathy dominated by focal accumulations of NF with axonal swellings (giant axons) and significant secondary demyelination; in the fifth case no NFs accumulations were evident but many myelinated fibres consisted exclusively of microtubules with few or absent NF. The pathological phenotype correlated with the pattern of nerve conduction alterations and indicated that NEFL mutations cause a profound alteration of the cytoskeleton possibly related to defective targeting of NF.

Key Words: Charcot–Marie–Tooth disease; neurofilament light chain subunit; giant axons; secondary demyelination; phenotype and genotype correlations

Abbreviations: CMT, Charcot–Marie–Tooth; MNCV, motor nerve conduction velocity; NF-L, neurofilament light; SNP, single nucleotide polymorphism

Received June 17, 2006. Revised August 19, 2006. Accepted August 23, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
D. W. Cleveland, K. Yamanaka, and P. Bomont
Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway
Hum. Mol. Genet., April 15, 2009; 18(8): 1384 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Zhai, H. Lin, J.-P. Julien, and W. W. Schlaepfer
Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot Marie Tooth disease-linked mutations in NFL and HSPB1
Hum. Mol. Genet., December 15, 2007; 16(24): 3103 - 3116.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Miltenberger-Miltenyi, A. R. Janecke, J. V. Wanschitz, V. Timmerman, C. Windpassinger, M. Auer-Grumbach, and W. N. Loscher
Clinical and Electrophysiological Features in Charcot-Marie-Tooth Disease With Mutations in the NEFL Gene
Arch Neurol, July 1, 2007; 64(7): 966 - 970.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.